Table 3 Determining the cutoff threshold of the expression of CD71 on neutrophils based on the metastatic spread using the two-tailed minimal p-value approach (chi-square test; n = 70).

From: CD71 expressing circulating neutrophils serve as a novel prognostic biomarker for metastatic spread and reduced outcome in pancreatic ductal adenocarcinoma patients

MFI CD71 (%)

p-value (chi-sqare test)

CD71 Expression

N

Probability of metastasis (%)

200

0.14

Low

5

0

High

65

44.4

250

0.05

Low

14

7.1

High

56

34.0

300

 < 0.01

Low

26

3.8

High

44

43.2

350

 < 0.01

Low

35

8.6

High

35

48.6

400

 < 0.01

Low

42

16.7

High

28

46.4

450

0.19

Low

53

24.5

High

17

41.2

500

0.26

Low

61

26.2

High

9

44.4

  1. The optimal cutoff value with the lowest p-value and the highest probability of metastatic spread is highlighted in bold.